Some users describe a brief sharp pain during needle insertion followed by a deeper burning sensation as the medication disperses under the skin
(eds Lambers, H., Van Der Plas, H
Country of Origin: EU (European Union)
43 The review of studies included in this analysis also reveals a potential link between the use of GLP-1 RAs and a reduced risk of dementia in AD patients, as well as a lower risk of mortality in dementia patients
1 , 5 8 GLP-1 receptor agonists have been shown to improve glycemic control by reducing fasting plasma glucose (FPG) and postprandial glucose (PPG), and to provide beneficial reductions in body weight in patients with T2D, 6 , 8 10 and in obese patients without T2D
doi: 10.1038/nm.3563 30 BesbesA.Le GoffS.AntunesA.TerradeA.HongE.GiorginiD.et al